These Analysts Increase Their Forecasts On Inspire Medical After Strong Q3 Results
Inspire Medical beat Q3 earnings and sales estimates, narrowed FY2026 guidance, while analysts raised price targets to $77 and $70.
Share
Why It Matters
Inspire Medical did better than experts predicted this quarter. When companies beat expectations, it often means they're running well and growing strong.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.